Clin2
NCT07130253Possibly a fitNot yet recruiting

New treatment for stubborn H. pylori infection

HELICOBACTER PYLORI INFECTIONS

Part of Digestive system clinical trials.

This trial tests a new combination of medicines to get rid of H. pylori bacteria in people whose previous treatments have not worked. It aims to find a more effective way to clear the infection.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
220 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You are 20 years old or older.
  • You have had at least two previous treatments for H. pylori that did not work.
  • You are willing to try a third treatment.
  • You have not had your stomach removed (gastrectomy).
  • You are not allergic to the study drugs or quinolone antibiotics, and are not pregnant or breastfeeding.
  • You do not have serious health conditions like kidney failure, liver cirrhosis, or certain cancers.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei
NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day course of two medicines, vonoprazan and minocycline, to see how well they clear an H. pylori stomach infection. If you have H. pylori and haven't been treated for it before, this study may help you get rid of the infection.

NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.